VF
IRD

Virtu Financial’s Opus Genetics IRD Stock Holding History

Virtu Financial’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,810
Closed -$34K – 2458
2025
Q4 		$34K Buy
+16,810
New +$34.1K ﹤0.01% 1349
2025
Q3 		– Sell
-79,346
Closed -$75K – 2240
2025
Q2 		$75K Buy
79,346
+53,071
+202% +$49.2K ﹤0.01% 1076
2025
Q1 		$26K Buy
+26,275
New +$29.4K ﹤0.01% 1080
2024
Q4 		– Sell
-23,728
Closed -$31K – 2201
2024
Q3 		$31K Buy
+23,728
New +$36.5K ﹤0.01% 1078
2024
Q2 		– Sell
-17,752
Closed -$36K – 1985
2024
Q1 		$36K Buy
+17,752
New +$45K ﹤0.01% 1078
2019
Q2 		– Sell
-1,292
Closed -$32K – 1945
2019
Q1 		$32K Buy
1,292
+343
+36% +$11.4K ﹤0.01% 1254
2018
Q4 		$42K Sell
949
-153
-14% -$8.94K ﹤0.01% 1292
2018
Q3 		$94K Sell
1,102
-664
-38% -$51.3K 0.01% 1203
2018
Q2 		$119K Buy
+1,766
New +$155K 0.01% 1616
2018
Q1 		– Sell
-305
Closed -$30K – 2728
2017
Q4 		$30K Buy
+305
New +$31K ﹤0.01% 2159

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Virtu Financial's IRD Position: Q1 2026 in Review

Virtu Financial sold out of Opus Genetics (IRD) in Q1 2026, closing a stake of 16,810 shares — an estimated $34K sold.

Virtu Financial first reported a position in IRD in Q4 2017 and held it in 10 quarters. The position peaked at $119K in Q2 2018. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Virtu Financial reported no remaining Opus Genetics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 16,810 Opus Genetics shares in Q1 2026, an estimated $34K.
  • Virtu Financial first reported a position in Opus Genetics in Q4 2017 and held it in 10 quarters.
  • Virtu Financial's Opus Genetics position peaked at $119K in Q2 2018.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.